These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 23382097)

  • 21. [Serum fibrosis markers in diagnosing liver fibrosis].
    Liu J; Wang JY; Lu Y
    Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):475-7. PubMed ID: 16831325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
    Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP
    J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic accuracy of biomarkers measured in the hepatic vein and peripheral vein in the prediction of advanced fibrosis in patients with chronic viral hepatitis.
    Suk KT; Kim DJ; Kim CH; Park SH; Cheong JY; Cho SW; Choi JY; Han KH; Sung HT; Hong SH; Kim DY; Yoon JH; Kim YS; Baik GH; Kim JB
    Clin Biochem; 2012 Sep; 45(13-14):1075-80. PubMed ID: 22579966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Procollagen-III peptide and chronic viral C hepatitis.
    Jeffers LJ; Coelho-Little ME; Cheinquer H; Vargas C; Civantos F; Alvarez L; Reddy KR; Parker T; de Medina M; Li X
    Am J Gastroenterol; 1995 Sep; 90(9):1437-40. PubMed ID: 7661165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive assessment of hepatic fibrosis and necroinflammatory activity in Egyptian children with chronic hepatitis C virus infection using FibroTest and ActiTest.
    El-Shabrawi MH; Mohsen NA; Sherif MM; El-Karaksy HM; Abou-Yosef H; El-Sayed HM; Riad H; Bahaa N; Isa M; El-Hennawy A
    Eur J Gastroenterol Hepatol; 2010 Aug; 22(8):946-51. PubMed ID: 20110820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble urokinase plasminogen activator receptor is associated with progressive liver fibrosis in hepatitis C infection.
    Berres ML; Schlosser B; Berg T; Trautwein C; Wasmuth HE
    J Clin Gastroenterol; 2012 Apr; 46(4):334-8. PubMed ID: 21934527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of a 5.9 kDa peptide C-terminal fragment of fibrinogen α chain precedes fibrosis progression in patients with liver disease.
    Marfà S; Crespo G; Reichenbach V; Forns X; Casals G; Morales-Ruiz M; Navasa M; Jiménez W
    PLoS One; 2014; 9(10):e109254. PubMed ID: 25275549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of fibrosis biomarkers measured early after liver transplantation are associated with severe hepatitis C virus recurrence.
    Micheloud D; Salcedo M; Bañares R; Rincón D; Lorente R; Muñoz-Fernández MA; Resino S
    Transpl Infect Dis; 2009 Apr; 11(2):183-8. PubMed ID: 19254326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis.
    Trebicka J; Anadol E; Elfimova N; Strack I; Roggendorf M; Viazov S; Wedemeyer I; Drebber U; Rockstroh J; Sauerbruch T; Dienes HP; Odenthal M
    J Hepatol; 2013 Feb; 58(2):234-9. PubMed ID: 23085648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chances and limitations of non-invasive tests in the assessment of liver fibrosis in liver transplant patients.
    Kamphues C; Lotz K; Röcken C; Berg T; Eurich D; Pratschke J; Neuhaus P; Neumann UP
    Clin Transplant; 2010; 24(5):652-9. PubMed ID: 19925459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between liver biopsy and fibrotest in the evaluation of hepatic fibrosis in patients with chronic hepatitis C.
    Said Y; Salem M; Mouelhi L; Mekki H; Houissa F; Ben Rejeb M; Moussa A; Trabelsi S; Debbeche R; Bouzaidi S; Najjar T
    Tunis Med; 2010 Aug; 88(8):573-8. PubMed ID: 20711964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single stage and multistage classification models for the prediction of liver fibrosis degree in patients with chronic hepatitis C infection.
    Hashem AM; Rasmy ME; Wahba KM; Shaker OG
    Comput Methods Programs Biomed; 2012 Mar; 105(3):194-209. PubMed ID: 22070853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue inhibitors of metalloproteinases in liver and serum/plasma in chronic active hepatitis C and HCV-induced cirrhosis.
    Böker KH; Pehle B; Steinmetz C; Breitenstein K; Bahr M; Lichtinghagen R
    Hepatogastroenterology; 2000; 47(33):812-9. PubMed ID: 10919037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.
    Vergniol J; Foucher J; Terrebonne E; Bernard PH; le Bail B; Merrouche W; Couzigou P; de Ledinghen V
    Gastroenterology; 2011 Jun; 140(7):1970-9, 1979.e1-3. PubMed ID: 21376047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection.
    Zeremski M; Dimova R; Brown Q; Jacobson IM; Markatou M; Talal AH
    J Infect Dis; 2009 Dec; 200(11):1774-80. PubMed ID: 19848607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
    Carvalho-Filho RJ; Schiavon LL; Narciso-Schiavon JL; Sampaio JP; Lanzoni VP; Ferraz ML; Silva AE
    Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis of advanced fibrosis in HIV and hepatitis C virus-coinfected patients via a new noninvasive index: the HGM-3 index.
    Resino S; Micheloud D; Miralles P; Bellón JM; Vargas A; Catalán P; Alvarez E; Cosín J; Lorente R; López JC; Muñoz-Fernández MA; Berenguer J
    HIV Med; 2010 Jan; 11(1):64-73. PubMed ID: 19686437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel serum biomarker candidates for liver fibrosis in hepatitis C patients.
    Gangadharan B; Antrobus R; Dwek RA; Zitzmann N
    Clin Chem; 2007 Oct; 53(10):1792-9. PubMed ID: 17702858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of a glycoproteomics-based biomarker development method: alteration in glycan structure on colony stimulating factor 1 receptor as a possible glycobiomarker candidate for evaluation of liver cirrhosis.
    Ocho M; Togayachi A; Iio E; Kaji H; Kuno A; Sogabe M; Korenaga M; Gotoh M; Tanaka Y; Ikehara Y; Mizokami M; Narimatsu H
    J Proteome Res; 2014 Mar; 13(3):1428-37. PubMed ID: 24422531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.